These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report. Edwards JG; Goldie A Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611 [TBL] [Abstract][Full Text] [Related]
4. A double-blind trial comparing mianserin and maprotiline in depressed inpatients. Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238 [TBL] [Abstract][Full Text] [Related]
5. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants. Cording-Tömmel C; von Zerssen D Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183 [TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people. Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479 [TBL] [Abstract][Full Text] [Related]
7. Mianserin versus maprotiline in patients with a depressive syndrome. Indaco A; Orefice G; Carrieri P Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655 [No Abstract] [Full Text] [Related]
8. Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Krijzer F; Snelder M; Bradford D Neuropsychobiology; 1984; 12(4):249-54. PubMed ID: 6442931 [TBL] [Abstract][Full Text] [Related]
9. Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram. Atri PB; Julius DA J Clin Psychopharmacol; 1984 Aug; 4(4):207-9. PubMed ID: 6470193 [TBL] [Abstract][Full Text] [Related]
10. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression. Möller HJ; Riehl T; Dietzfelbinger T; Wernicke T Int Clin Psychopharmacol; 1991; 6(3):179-92. PubMed ID: 1806624 [TBL] [Abstract][Full Text] [Related]
11. Epileptiform seizures with maprotiline hydrochloride. Marks P; Anderson J; Vincent R; Hutchinson JT; Rees HM Postgrad Med J; 1979 Oct; 55(648):742. PubMed ID: 537962 [TBL] [Abstract][Full Text] [Related]
12. Antidepressants and convulsions. Edwards JG Lancet; 1979 Dec 22-29; 2(8156-8157):1368-9. PubMed ID: 92708 [No Abstract] [Full Text] [Related]
13. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline. Montgomery S; Cronholm B; Asberg M; Montgomery DB Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948 [No Abstract] [Full Text] [Related]
14. A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake. Harper B; Hughes IE Br J Pharmacol; 1977 Apr; 59(4):651-60. PubMed ID: 870126 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the cardiac effects of mianserin and amitriptyline in man. Peet M; Tienari P; Jaskari MO Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):309-12. PubMed ID: 360245 [TBL] [Abstract][Full Text] [Related]